Literature DB >> 10495797

Membranous glomerulonephritis.

A G Wasserstein1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 10495797     DOI： 10.1681/ASN.V84664

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  33 in total

1.  Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.

Authors:  Corrado Murtas; Maurizio Bruschi; Giovanni Candiano; Gabriella Moroni; Riccardo Magistroni; Andrea Magnano; Francesca Bruno; Antonella Radice; Luciana Furci; Lucia Argentiero; Maria Luisa Carnevali; Piergiorgio Messa; Francesco Scolari; Renato Alberto Sinico; Loreto Gesualdo; Fernando C Fervenza; Landino Allegri; Pietro Ravani; Gian Marco Ghiggeri
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

2.  A case of glomerulopathy showing podocytic infolding in association with Sjögren's syndrome and primary biliary cirrhosis.

Authors:  Kentaro Koike; Yasunori Utsunomiya; Yoriko Ito; Satori Tokudome; Yoichi Miyazaki; Takahide Suzuki; Hideo Okonogi; Tetsuya Kawamura; Akio Yamada; Tatsuo Hosoya; Kensuke Joh
Journal:  Clin Exp Nephrol       Date:  2008-10-07       Impact factor: 2.801

3.  Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis.

Authors:  Shuzo Sato; Rie Saito; Haruyo Iwadate; Tomoyuki Asano; Kazumichi Abe; Atsushi Takahashi; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2012-07-20

4.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

Review 5.  Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis.

Authors:  Mariadelina Simeoni; Ramona Nicotera; Maria Colao; Maria Lucia Citraro; Elena Pelagi; Annamaria Cerantonio; Nicola Comi; Giuseppe Coppolino; Giorgio Fuiano
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

6.  A large-sized bubbling appearance of the glomerular basement membrane in a patient with pulmonary limited AL amyloidosis and a past history of lupus nephritis.

Authors:  Norihiro Suga; Naoto Miura; Yuko Uemura; Toshinobu Nakamura; Hiroyuki Morita; Shogo Banno; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2011-08-30       Impact factor: 2.801

7.  Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin.

Authors:  L M Endo; J V Giannobile; A K Dobbs; J B Foote; E Szymanska; D G Warnock; W J Cook; M E Conley; H W Schroeder
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

Review 8.  Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome.

Authors:  Ramesh Khanna
Journal:  Mo Med       Date:  2011 Jan-Feb

Review 9.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

10.  CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Authors:  Paul Gutwein; Mohamed Sadek Abdel-Bakky; Anja Schramme; Kai Doberstein; Nicole Kämpfer-Kolb; Kerstin Amann; Ingeborg A Hauser; Nicholas Obermüller; Christine Bartel; Abdel-Aziz H Abdel-Aziz; El Sayed M El Sayed; Josef Pfeilschifter
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.